Factor V Leiden Thrombophilia Latest Advances
Find the Latest Research About Factor V Leiden Thrombophilia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1312 publications
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry study.
Journal: Rheumatology (Oxford, England)
Published: February 11, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with aPLs: an APS ACTION Registry study.
Journal: Rheumatology (Oxford, England)
Published: February 11, 2026
Real-world data on Factor V Leiden in Sweden: A nationwide family study.
Journal: Journal of thrombosis and thrombolysis
Published: February 06, 2026
Activated Protein C Sensitivity Assessed with Thrombin Generation Assay in Antiphospholipid Syndrome Women: Results from Two French Cohorts.
Journal: Thrombosis and haemostasis
Published: January 28, 2026
Pseudonaja textilis venom factor Va circumvents natural regulatory mechanisms via a unique A2 domain region.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 02, 2025
Association of factor V leiden and ischemic stroke in young adults: a national inpatient sample analysis.
Journal: Journal of thrombosis and thrombolysis
Published: November 24, 2025
Diagnosing thrombophilia: the case for genetic or functional testing?
Journal: Expert review of molecular diagnostics
Published: November 10, 2025
Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives.
Journal: Research and practice in thrombosis and haemostasis
Published: October 23, 2025
Assessment of thrombophilia in patients with lupus anticoagulant.
Journal: Thrombosis research
Published: June 13, 2025
Last Updated: 09/26/2026